Does DABIGATRAN Cause Coronary artery disease? 17 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Coronary artery disease have been filed in association with DABIGATRAN. This represents 0.8% of all adverse event reports for DABIGATRAN.
17
Reports of Coronary artery disease with DABIGATRAN
0.8%
of all DABIGATRAN reports
1
Deaths
8
Hospitalizations
How Dangerous Is Coronary artery disease From DABIGATRAN?
Of the 17 reports, 1 (5.9%) resulted in death, 8 (47.1%) required hospitalization.
Is Coronary artery disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DABIGATRAN. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does DABIGATRAN Cause?
Gastrointestinal haemorrhage (210)
Hypotension (167)
Atrial fibrillation (150)
Drug interaction (143)
Haemorrhage (141)
Anaemia (131)
Dizziness (123)
Acute kidney injury (120)
Drug ineffective (118)
Fall (117)
What Other Drugs Cause Coronary artery disease?
ROSIGLITAZONE (4,982)
ASPIRIN (807)
METFORMIN\ROSIGLITAZONE (738)
AVANDIA (667)
ROSUVASTATIN (508)
TESTOSTERONE (453)
PANTOPRAZOLE (422)
CLOPIDOGREL BISULFATE (402)
ALBUTEROL (391)
ADALIMUMAB (353)
Which DABIGATRAN Alternatives Have Lower Coronary artery disease Risk?
DABIGATRAN vs DABIGATRAN ETEXILATE
DABIGATRAN vs DABRAFENIB
DABIGATRAN vs DABRAFENIB\TRAMETINIB
DABIGATRAN vs DACARBAZINE
DABIGATRAN vs DACLATASVIR